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The aim of this study was to evaluate the 
efficacy and safety of Directional Coronary 
Atherectomv (DCA) of lesions with unfavorable 
angiograihic morphologies for balldon 
angioplasties. Of 308 lesions in 260 patients 
who underwent DCA, angiograms of 290 lesions 
were analyzed for lesion length, eccentricity, 
abnormal contour (ulceration, dissection, flap) 
and calcification‘. The le$ion length/vessel 
diameter ratio (LDR) was determined. Overall 
success rate and coronary artery surgery (CABG) 
rate were 91% and 3.1%. 
Flap or 
Success Dissection CABG 
LDR Short (<31 21L9 92% 13% 3.2% 
tong i>sj 67 87% 12% 3.0% 
Concentr iE 166 92% 10% 2.4% 
Eccentric 124 90% 16% 4.04 
Normal contour 244 91% 12% 2.5% 
Abnormal contour 46 89% 15% 6.58 
No calcification 242 96% 10% 2.1% 
Calcification 48 *69% +*27% “**8.3% 
(*p<O.OOOl **p=O.O04 ***p=O.O6) 
In conclusion, fiCA is effective and safe for 
certain unfavorable angiographic morphology, 
however presence of calcification is associated 
with reduced success rate with higher incidence 
of dissection. 
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To assess the benefit of PTCA in occluded and 6tenOsed coronary arteries 
supplying a viable myocardium, we measured the coronary blood flow 
velocity (CBFV) using a 3F coronary dopplet catheter in 24 patients (14 
steno666, 10 occlusions of the proximal or mid arterial segment). The 
doppler Cathetertip was positioned in the proximal segment of the involved 
vessel. Heert rate (HR) and mean aortic pressure (MAP) were monitored 
oaring the procedure. An index of coronary vascular resistance 
derl;ed from th66e values: CVRMvlAPICBFV. The measurement6 
made before and immrjdiately after a successful PTCA (angiographic 
residual stenosis S.?t)%), at rest and during maxlmal hyperemia using 
intracoronary injection of rine. We aiS aSSe666d coronary 
vasodilator reserve (RES) as the ratio of hyp6remiC to rest 
velocities. 
before PTCA 
rest hyperemia emia 
CBRl 16.2f3.4 36.7f7.1 10.9 
7.2f1.2 * 21 aOf5.2 19.2ti2.4 53.9f6.0 
CVRI ST 7.5&l * 1 3.1 f0.4 5.2f0.7 1 e6f0.2 
ooc 14.9f3.4 * 7.lti.3 5.4fl .o 1.9fO.3 
PES ST 2.4k5.2 2 5f0.2 
2.8zt0.5 2.9f0.3 
OCC=occlusion ’ VS Stenosis ps.05 
rence in coronary blood flow observed bekra PTC 
stenoeee and occlusions is not observed afler successful PTCA, 
that the benefit of recanalization may be similar in stenoses and occlusions. 
2) The lack of significant difference in hypersmic Change6 before PTCA 
between 61enos66 and ocilusions may be due to the response of collateral 
vessels. 
William S. Weintraub M.D., FACE, Ziyad MB. G M.D., John 8. 
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The prognosis after succwful PTCA remains unclear. It is known that 
restenosis is unusual after 6 months, but the implications of this for other 
clinical events is unknown. Tbm we identaed 1544 patients without prior 
CABG who were shown by aqiography to have all sites previously dilated lo be 
patent at 6 to 12 months after electke aagioplasty (proven Patency). 1487 
(91%) were contacted for followup. Fhe year freedom from (FF) events, 
catb. Ifthere were no remaining obstructiofui the FF from cardiac dcaatb, MIor 
CARG was $8 at 2 years and .89 
obstructions the FF from cardiac death, 
If there were remahiq 
Gwas.9Oat2parsaad.79 
at five years @<.ow)l compared to no remaining obstructions). Survival aad 
freedom from Ml in the setting of proven patency is excellent. With mukssel 
disease or remain&t obstructions there is a higher rate of events. EIRB if 
re6tenosis is avoided, the ability to provide complete revwularization, and 
ultimately halt progression remains a high priority. 
